Home / Products / Cancer (Tumor) Cell Lines / RT-4
RT-4
Datasheet Protocol

RT-4

Cat. No. ARC0786
Product Type:

Cancer (Tumor) Cell Lines

Species:

Homo sapiens (Human)

Tissue Source:

Urinary bladder

Growth Properties:

Adherent

In stock
$1,300.00 / Vial
Ask a Question

Short Description 🔒

RT-4 is a cancer cell line of urinary bladder carcinoma, isolated from in situ; urinary bladder.
 
Synonym: RT4; RT4P

Recommended Products

SELENOI Knockout HCT 116 Cell Line SELENOI Knockout HCT 116 Cell Line Cat. No. ARG44101 ATF3 Knockout HT-1080 Cell Line ATF3 Knockout HT-1080 Cell Line Cat. No. ARG43731 NEK7 Knockout jurkat Polyclonal Cells NEK7 Knockout jurkat Polyclonal Cells Cat. No. ARG13162 Cntn1 Knockout Hela Polyclonal Cells Cntn1 Knockout Hela Polyclonal Cells Cat. No. ARG9093 ANKRD26 Knockout 786-O Polyclonal Cells ANKRD26 Knockout 786-O Polyclonal Cells Cat. No. ARG24905 Rat Spinal Cord Microvascular Endothelial Cell Medium Rat Spinal Cord Microvascular Endothelial Cell Medium Cat. No. ARM0358
Product Details
Cell Engineering
Immortalization
Culture Conditions
Quality Control
Disclaimer

Product Details

Product Type:
Cancer (Tumor) Cell Lines
Species:
Homo sapiens (Human)
Tissue Source:
Urinary bladder
Disease:
Carcinoma
Morphology:
Epithelial-like
Growth Mode:
Adherent
Age:
63 years
Sex of Donor:
Male
Derived From Site:
In situ; Urinary bladder
Size/Quantity:
1 million
Shipping info:
Cryopreserved in vials and shipped on dry ice

Cell Engineering Information

No cell engineering information available.

Immortalization Information

No immortalization information available.

Culture Conditions

Temperature:
37°C
Atmosphere:
5% CO₂

Quality Control

Mycoplasma testing:
Negative for mycoplasma through PCR analysis
Sterility testing:
Daily monitoring confirms that the cells are free from bacterial, yeast, and fungal contamination.
Pathogens:
Cells tested negative for HIV-1, HBV, and HCV.

Disclaimer

Intended Use:
This product is intended for laboratory in vitro use only. It is not intended for diagnostic, therapeutic, or clinical applications.
Disclaimer:
Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability.
Usage:
By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use. This product is provided "AS IS".

Description 🔒

Complete description is available upon request.

Related Products You May Also Like

CALD1 Knockout HAP1 Polyclonal Cells

CALD1 Knockout HAP1 Polyclonal Cells

Cat. No. ARG41828
 BBC3 Knockout 786-O Polyclonal Cells

BBC3 Knockout 786-O Polyclonal Cells

Cat. No. ARG25064
 HPRT1 Knockout jurkat Polyclonal Cells

HPRT1 Knockout jurkat Polyclonal Cells

Cat. No. ARG34276
 ANXA5 Knockout HAP1 Polyclonal Cells

ANXA5 Knockout HAP1 Polyclonal Cells

Cat. No. ARG34958
 EFNB2 Knockout HEK293T Polyclonal Cells

EFNB2 Knockout HEK293T Polyclonal Cells

Cat. No. ARG40705
 DNAL1 Knockout NCI-H1975 Polyclonal Cells

DNAL1 Knockout NCI-H1975 Polyclonal Cells

Cat. No. ARG39360